IN2014MN00955A - - Google Patents
Info
- Publication number
- IN2014MN00955A IN2014MN00955A IN955MUN2014A IN2014MN00955A IN 2014MN00955 A IN2014MN00955 A IN 2014MN00955A IN 955MUN2014 A IN955MUN2014 A IN 955MUN2014A IN 2014MN00955 A IN2014MN00955 A IN 2014MN00955A
- Authority
- IN
- India
- Prior art keywords
- immunomodulator
- therapy
- ultrasound
- embolisation
- cyberknife
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1120779.2A GB201120779D0 (en) | 2011-12-02 | 2011-12-02 | Cancer therapy |
PCT/GB2012/052992 WO2013079980A1 (en) | 2011-12-02 | 2012-12-03 | Immunogenic treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN00955A true IN2014MN00955A (ru) | 2015-04-24 |
Family
ID=45509083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN955MUN2014 IN2014MN00955A (ru) | 2011-12-02 | 2012-12-03 |
Country Status (15)
Country | Link |
---|---|
US (4) | US20140356397A1 (ru) |
EP (1) | EP2785361B1 (ru) |
JP (1) | JP6085611B2 (ru) |
KR (1) | KR20140097419A (ru) |
CN (1) | CN104023733A (ru) |
AU (1) | AU2012343536B2 (ru) |
BR (1) | BR112014012880A2 (ru) |
CA (1) | CA2857429A1 (ru) |
GB (1) | GB201120779D0 (ru) |
IL (1) | IL232890A0 (ru) |
IN (1) | IN2014MN00955A (ru) |
MX (1) | MX2014006511A (ru) |
RU (1) | RU2014121335A (ru) |
SG (1) | SG11201402396XA (ru) |
WO (1) | WO2013079980A1 (ru) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11963716B2 (en) | 2010-07-19 | 2024-04-23 | Emblation Limited | Apparatus and method for the treatment of dermatological diseases or conditions |
GB201120779D0 (en) * | 2011-12-02 | 2012-01-11 | Immodulon Therapeutics Ltd | Cancer therapy |
GB201308325D0 (en) * | 2013-05-09 | 2013-06-19 | Immodulon Therapeutics Ltd | Cancer Therapy |
EA201691073A1 (ru) * | 2013-12-05 | 2016-12-30 | РФЕМБ ХОЛДИНГС, ЭлЭлСи | Иммунотерапия рака с помощью радиочастотного электрического пробоя мембраны (rf-emb) |
GB201322725D0 (en) * | 2013-12-20 | 2014-02-05 | Immodulon Therapeutics Ltd | Cancer therapy |
KR102128856B1 (ko) * | 2015-01-30 | 2020-07-02 | 알에프이엠비 홀딩스, 엘엘씨 | 고주파 전기적 막 파괴를 이용하여 생명체의 바람직하지 않은 연조직을 절제하는 시스템 |
CA2990107A1 (en) | 2015-06-24 | 2016-12-29 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
RU2596505C1 (ru) * | 2015-07-02 | 2016-09-10 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский радиологический центр" Министерства здравоохранения Российской Федерации (ФГБУ "НМИРЦ" Минздрава России) | Способ лечения онкологических больных цитотоксическими лимфоцитами |
US10478194B2 (en) * | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US11612426B2 (en) | 2016-01-15 | 2023-03-28 | Immunsys, Inc. | Immunologic treatment of cancer |
AU2017249500A1 (en) * | 2016-04-14 | 2018-11-01 | Feldreich Caro Ruiz AB | An apparatus for use in irradiation therapy comprising ionization module and UV-light source |
EP3600551A1 (en) | 2017-03-28 | 2020-02-05 | Emblation Limited | Stenosis treatment |
EP3654976A1 (en) | 2017-07-21 | 2020-05-27 | Varian Medical Systems, Inc. | Methods of use of ultra-high dose rate radiation and therapeutic agents |
RU2664597C1 (ru) * | 2017-12-12 | 2018-08-21 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) | Способ комбинированного лечения больных первично операбельным и местно-распространенным неоперабельным раком молочной железы |
CN113164632A (zh) | 2018-12-03 | 2021-07-23 | 融合制药公司 | 放射性免疫缀合物与检查点抑制剂组合疗法 |
AU2020414040A1 (en) * | 2019-12-27 | 2022-08-18 | Zeria Pharmaceutical Co., Ltd. | Cancer treatment method and medicine |
WO2023007107A1 (en) * | 2021-07-27 | 2023-02-02 | Immodulon Therapeutics Limited | A mycobacterium for use in cancer therapy |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5207223A (en) | 1990-10-19 | 1993-05-04 | Accuray, Inc. | Apparatus for and method of performing stereotaxic surgery |
DE69126668T2 (de) * | 1990-11-08 | 1997-10-23 | Univ London | Mycobacterium als adjuvans für antigene |
US5458125A (en) | 1994-01-28 | 1995-10-17 | Board Of Directors Of The Leland Standford Jr. University | Treatment planning method and apparatus for radiosurgery and radiation therapy |
US20020022032A1 (en) | 1999-04-23 | 2002-02-21 | Curry Patrick Mark | Immuno-adjuvant PDT treatment of metastatic tumors |
WO2000064476A2 (en) | 1999-04-23 | 2000-11-02 | Qlt Inc. | Immuno-adjuvant pdt treatment of metastatic tumors |
WO2003049751A1 (en) * | 2001-12-10 | 2003-06-19 | Bakulesh Mafatlal Khamar | The process of manufacturing a pharmaceutical composition useful for management of cancer |
ATE481985T1 (de) | 2002-07-03 | 2010-10-15 | Ono Pharmaceutical Co | Immunpotenzierende zusammensetzungen |
US20050175625A1 (en) | 2002-07-12 | 2005-08-11 | The Johns Hopkins University | Mesothelin vaccines and model systems |
AU2006306521B2 (en) | 2005-10-21 | 2011-12-22 | Medical College Of Georgia Research Institute, Inc. | The induction of indoleamine 2,3-dioxygenase in dendritic cells by TLR ligands and uses thereof |
US20080318252A1 (en) | 2007-04-23 | 2008-12-25 | Scott Kachlany | Rapid assay to test anti-cancer drugs under physiological conditions |
GB0526033D0 (en) * | 2005-12-21 | 2006-02-01 | Bioeos Ltd | Method |
WO2007112316A2 (en) * | 2006-03-24 | 2007-10-04 | Morton Donald L | Mycobacterial immunotherapy for cancer treatment |
WO2008110491A2 (en) | 2007-03-09 | 2008-09-18 | University Of Basel | Chemotherapy of neoplastic diseases using combinations of rapamycin and compounds modulating mtor pathway alone or in combination with heat |
KR101586617B1 (ko) | 2007-06-18 | 2016-01-20 | 머크 샤프 앤 도메 비.브이. | 사람 프로그램된 사멸 수용체 pd-1에 대한 항체 |
ES2536465T3 (es) * | 2008-10-01 | 2015-05-25 | Immatics Biotechnologies Gmbh | Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres |
US8367075B2 (en) | 2010-07-02 | 2013-02-05 | Indian Institute Of Science | Synergistic combination and method thereof |
JP2014511396A (ja) * | 2011-03-09 | 2014-05-15 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 除去的放射線治療に使用される組成物およびその使用方法 |
CN103796680A (zh) | 2011-06-21 | 2014-05-14 | 约翰霍普金斯大学 | 用于增强针对赘生物的基于免疫的治疗的聚焦放射 |
GB201120779D0 (en) * | 2011-12-02 | 2012-01-11 | Immodulon Therapeutics Ltd | Cancer therapy |
EP2620159A1 (en) | 2012-01-24 | 2013-07-31 | Institut Pasteur | Improved cancer treatment by immunotherapy with bcg or antigenically related non-pathogenic mycobacteria |
CA2848985A1 (en) | 2012-02-01 | 2013-08-08 | Compugen Ltd. | C10rf32 antibodies, and uses thereof for treatment of cancer |
US8617520B2 (en) | 2012-02-15 | 2013-12-31 | Immodulon Therapeutics Limited | Cancer therapy |
GB201308325D0 (en) | 2013-05-09 | 2013-06-19 | Immodulon Therapeutics Ltd | Cancer Therapy |
GB201322725D0 (en) | 2013-12-20 | 2014-02-05 | Immodulon Therapeutics Ltd | Cancer therapy |
KR102395498B1 (ko) | 2014-01-06 | 2022-05-09 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | Pd1 및 pdl1 항체 및 백신 조합 및 면역요법을 위한 이들의 사용 |
US10975112B2 (en) | 2015-06-16 | 2021-04-13 | Hangzhou Dac Biotech Co., Ltd. | Linkers for conjugation of cell-binding molecules |
CA2990107A1 (en) | 2015-06-24 | 2016-12-29 | Immodulon Therapeutics Limited | A checkpoint inhibitor and a whole cell mycobacterium for use in cancer therapy |
CN112672758A (zh) | 2018-06-25 | 2021-04-16 | 英摩杜伦治疗学公司 | 癌症治疗 |
-
2011
- 2011-12-02 GB GBGB1120779.2A patent/GB201120779D0/en not_active Ceased
-
2012
- 2012-12-03 CA CA2857429A patent/CA2857429A1/en not_active Abandoned
- 2012-12-03 MX MX2014006511A patent/MX2014006511A/es unknown
- 2012-12-03 IN IN955MUN2014 patent/IN2014MN00955A/en unknown
- 2012-12-03 SG SG11201402396XA patent/SG11201402396XA/en unknown
- 2012-12-03 US US14/361,992 patent/US20140356397A1/en not_active Abandoned
- 2012-12-03 CN CN201280059421.0A patent/CN104023733A/zh active Pending
- 2012-12-03 AU AU2012343536A patent/AU2012343536B2/en active Active
- 2012-12-03 KR KR1020147016935A patent/KR20140097419A/ko not_active Application Discontinuation
- 2012-12-03 EP EP12799260.0A patent/EP2785361B1/en active Active
- 2012-12-03 WO PCT/GB2012/052992 patent/WO2013079980A1/en active Application Filing
- 2012-12-03 JP JP2014543984A patent/JP6085611B2/ja active Active
- 2012-12-03 RU RU2014121335A patent/RU2014121335A/ru unknown
- 2012-12-03 BR BR112014012880A patent/BR112014012880A2/pt not_active IP Right Cessation
-
2014
- 2014-05-29 IL IL232890A patent/IL232890A0/en unknown
-
2018
- 2018-12-19 US US16/225,028 patent/US11318193B2/en active Active
-
2020
- 2020-06-30 US US16/916,194 patent/US11554166B2/en active Active
-
2023
- 2023-01-13 US US18/154,177 patent/US20230149525A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2012343536B2 (en) | 2017-08-24 |
US11318193B2 (en) | 2022-05-03 |
JP6085611B2 (ja) | 2017-02-22 |
WO2013079980A1 (en) | 2013-06-06 |
EP2785361A1 (en) | 2014-10-08 |
CN104023733A (zh) | 2014-09-03 |
US20230149525A1 (en) | 2023-05-18 |
US20200338181A1 (en) | 2020-10-29 |
US11554166B2 (en) | 2023-01-17 |
SG11201402396XA (en) | 2014-10-30 |
AU2012343536A1 (en) | 2014-06-05 |
BR112014012880A2 (pt) | 2017-06-13 |
EP2785361B1 (en) | 2018-11-28 |
IL232890A0 (en) | 2014-07-31 |
NZ624994A (en) | 2016-10-28 |
RU2014121335A (ru) | 2016-01-27 |
KR20140097419A (ko) | 2014-08-06 |
GB201120779D0 (en) | 2012-01-11 |
JP2014533743A (ja) | 2014-12-15 |
US20140356397A1 (en) | 2014-12-04 |
MX2014006511A (es) | 2014-12-05 |
US20190224294A1 (en) | 2019-07-25 |
CA2857429A1 (en) | 2013-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN00955A (ru) | ||
WO2011137449A3 (en) | Method and apparatus for treatment of ocular tissue using combined modalities | |
Mellal et al. | Thermal therapy modalities for cancer treatment: A review and future perspectives | |
WO2015008154A3 (en) | Self-administrable method, system, and apparatus for non-invasive neurostimulation therapy of the brain | |
US20240123253A1 (en) | Photodynamic therapy devices, systems and methods | |
Ross et al. | Laser-tissue interactions | |
Yin et al. | Characteristic analysis of light and heat transfer in photothermal therapy using multiple-light-source heating strategy | |
CN103638606B (zh) | 光热和光动力治疗装置 | |
CN203663257U (zh) | 光热和光动力治疗装置 | |
WO2013166504A3 (en) | Targeted delivery of active agents using thermally stimulated large increase of perfusion by high intensity focused ultrasound | |
Yanase et al. | Hyperthermia enhances the antitumor effect of photodynamic therapy with ALA hexyl ester in a squamous cell carcinoma tumor model | |
Yoo et al. | Non-ablative fractional thulium laser irradiation suppresses early tumor growth | |
RU2006101260A (ru) | Способ фотодинамической терапии онкологических заболеваний | |
RU2010129236A (ru) | Способ лечения местнораспространенных онкологических заболеваний в эксперименте | |
Lloyd et al. | Laser-Tissue Interactions | |
RU2015131129A (ru) | Способ фотодинамической терапии фоновых и предраковых заболеваний шейки матки | |
Liu et al. | Biophotonics in photomedicine | |
PH12015502086A1 (en) | Ablative immunotherapy | |
Kim et al. | Multi-Lens Array (MLA)-Assisted Power-Modulated Photothermal Therapy for Enhanced Cancer Treatment | |
Karimian et al. | Review the effect of hyperthermia using iron and magnetic nanoparticles in cancer treatment in chemical injuries | |
Soni et al. | Spatiotemporal Temperature in a Tumor During Nanorod Assisted Thermal Therapy | |
Moretti et al. | Conventional and unconventional use of lasers in skin disorders | |
Ioritani | Contact Laser Vaporization of Prostate (CVP) using 980 nm High Power Diode Laser and End-Firing TwisterTM Large Fiber | |
Lee et al. | Use of a 595-nm pulsed-dye laser to treat post-procedure ecchymoses | |
Betz et al. | Interstitial PDT Cancer Treatment |